Research and development of radiopharmaceuticals for targeted alpha particle therapy
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21340%2F17%3A00314149" target="_blank" >RIV/68407700:21340/17:00314149 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Research and development of radiopharmaceuticals for targeted alpha particle therapy
Original language description
The therapy of oncological diseases with alpha particle emitting nuclides belongs to the fastest developing fields of nuclear medicine. The basic aspects and specific issues of labelling with alpha particle emitters in general and the possibilities of 223Ra use in targeted alpha particle therapy are discussed in this work, together with the possible use of inorganic nanoparticles as prospective nuclear recoil resistant carriers of nuclides decaying by several alpha particle emissions.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
10402 - Inorganic and nuclear chemistry
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů